Journals / Turkish Journal of Medical Sciences / 2018 / Cilt: 48 - Sayı: 1

Is the extent of surgical resection important in patient outcome in benign and borderline phyllodes tumors of the breast?

Pages
28–33
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Asmost tumors recur within 2 years of diagnosis, we propose a close clinical and imaging follow-up during this period.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Phyllodes tumors (PTs) of the breast are rare, and their diagnosis and treatment remain controversial.
📊
Key Findings & Data:Thisretrospective study aims to examine the clinical outcome of benign and borderline PTs, according to the surgical margins.Materials and methods: We examined the medical records of 122 patients in our clinic, who had histologically confirmed benign andborderline PTs between 1994 and 2017.Results: The mean age of the patients was 40.6 years (range 18.0–81.0, ±12.1 standard deviation [SD]) and the mean tumor size was 25.8mm (range 9–65, ±10.3 SD).
💡
Conclusion & Impact:Asmost tumors recur within 2 years of diagnosis, we propose a close clinical and imaging follow-up during this period.
🔬Design:Research Article
📍Scope:2017 Verileri
⚙️Variables:Domain Parameters

Abstract

Background/aim: Phyllodes tumors (PTs) of the breast are rare, and their diagnosis and treatment remain controversial. Thisretrospective study aims to examine the clinical outcome of benign and borderline PTs, according to the surgical margins.Materials and methods: We examined the medical records of 122 patients in our clinic, who had histologically confirmed benign andborderline PTs between 1994 and 2017.Results: The mean age of the patients was 40.6 years (range 18.0–81.0, ±12.1 standard deviation [SD]) and the mean tumor size was 25.8mm (range 9–65, ±10.3 SD). All patients underwent a breast-conserving procedure and the median follow-up was 51 months. Tumormargins were positive (tumor touching the ink) in 43 patients (35%). Only 16 patients (13%) had margins ≥10 mm. The margins werebetween 2 and 10 mm in most patients (40%) and ≤1 mm in 12% of the patients.Conclusion: Although no re-excision was performed to obtain grossly clear margins, local recurrence was not observed in any patients.Therefore, revision surgery for close or positive surgical margins for benign and borderline PTs should not be performed as a rule. Asmost tumors recur within 2 years of diagnosis, we propose a close clinical and imaging follow-up during this period.

🔖

Cite This Article

DURAK, M. G., BALCI, P., AKSOY, S. Ö., SEVİNÇ, A. İ. (2022). Is the extent of surgical resection important in patient outcome in benign and borderline phyllodes tumors of the breast?. Turkish Journal of Medical Sciences, Cilt: 48 - Sayı: 1, 28–33. https://ajindex.com/articles/610403

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Dyer NH, Bridger JE, Taylor RS. Cystosarcoma phylloides. Br J Surg 1966; 53: 450-455. Buchanan EB. Cystosarcoma phyllodes and its surgical management. Am Surg 1995; 61: 350-355. Muller J. Uber den Feineren Ban und Die Formen der Krankaften Geschwulste. Vol. 1. Berlin, Germany: Greiner, 1838 (in German). World Health Organization. The World Health Organization histological typing of breast tumors—second edition. Am J Clin Pathol 1982; 78: 806-816.
  2. Cheng SP, Chang YC, Liu TP, Lee JJ, Tzen CY, Liu CL. Phylloides tumor of the breast: the challenge persists. World J Surg 2006; 30: 1414-1421.
  3. Barth RJ Jr, Wells WA, Mitchell SE, Cole BF. A prospective, multiinstitutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors. Ann Surg Oncol 2009; 16: 2288- 2294. Tse GMK, Niu Y, Shi HJ. Phyllodes tumor of the breast: an update. Breast Cancer 2010; 17: 29-34.
  4. Duman L, Gezer NS, Balcı P, Altay C, Başara I, Durak MG, Sevinç AI. Differentiation between phyllodes tumors and fibroadenomas based on mammographic sonographic and MRI features. Breast Care 2016; 11: 123-127.
  5. August AD, Kearney T. Cystosarcoma phyllodes: mastectomy, lumpectomy, or lumpectomy plus irradiation. Surg Oncol 2000; 9: 49-52.
  6. Jacklin RK, Ridgway PF, Ziprin P, Healy V, Hadjiminas D, Darzi A. Optimising preoperative diagnosis in phyllodes tumor of the breast. J Clin Pathol 2006; 59: 454-459.
  7. Bhargav PR, Mishra A, Agarwal G, Agarwal A, Verma AK, Mishra SK. Phyllodes tumor of the breast: clinicopathological analyses of recurrent vs. non-recurrent cases. Asian J Surg 2009; 32: 224-228.
  8. Chen WH, Cheng SP, Tzen CY, Yang TL, Jeng KS, Lıu CL, Lıu TP. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases. J Surg Oncol 2005; 91: 185- 194. Tan H, Zhang S, Liu H, Peng W, Li R, Gu Y, Wang X, Mao J, Shen X. Imaging findings in phyllodes tumors of the breast. Eur J Radiol 2012; 81: e62-69. Tan BY, Acs G, Apple SK, Badve S, Bleiweiss IJ, Brogi E, Calvo JP, Dabbs DJ, Ellis IO, Eusebi V et al. Phyllodes tumors of the breast: a consensus review. Histopathology 2016; 68: 5-21.
  9. Yom CK, Han W, Kim SW, Park SY, Park IA, Noh DY. Reappraisal of conventional risk stratification for local recurrence based on clinical outcomes in 285 resected phyllodes tumors of the breast. Ann Surg Oncol 2015; 22: 2912-2918.
  10. Ward ST, Jewkes AJ, Jones BG, Chaudri S, Hejmadi RK, Ismail T, Hallissey MT. The sensitivity of needle core biopsy in combination with other investigations for the di